Bart Carter, MD
General Surgery · Safford, AZNPI 1407850308
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Medtronic at 24.3% of the total. Reporting peaked in 2022 at $79 and has fallen 80.1% since, to $16 in 2025.
Across 18 payments — averaging $17.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$75
- Merck$71
- Innocoll Pharmaceuticals Limited$64
- Ortho-clinical Diagnostics, Inc.$35
- Baxter Healthcare$22
- Mimedx Group, Inc.$16
- plus $25 from 2 others
What the payments were for
- Food & beverage$307100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 3 | $75 |
| Merck | 6 | $71 |
| Innocoll Pharmaceuticals Limited | 4 | $64 |
| Ortho-clinical Diagnostics, Inc. | 1 | $35 |
| Baxter Healthcare | 1 | $22 |
| Mimedx Group, Inc. | 1 | $16 |
| Acacia Pharma Inc | 1 | $14 |
| Covidien LP | 1 | $12 |
How this compares
$307 in reported general payments places this provider in the 75th percentile of 24 general surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 13 | $233 |
| Calcitriol | 12 | $186 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $116 |
| Carvedilol | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other general surgery in Safford
- Donald GreenGoodyear$14K
- Tom WolvosScottsdale$9K
- Suemoy WallaceMesa$6K
- Jason PrimusScottsdale$5K
- Vilas DeshpandeSurprise$317
- Loyd OlsonPhoenix$26
- Diana McPheeScottsdale$22
- Alyssa ChapitalPhoenix$0
- Jeffrey SingerPhoenix$0
- Daniel JohnsonScottsdale$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.